In This Article:
As the Australian market edges back towards 8,000 points amidst global economic shifts and sector-wide gains, investors are closely watching developments that could influence dividend stocks. In this dynamic environment, strong dividend stocks often stand out for their potential to provide consistent income, especially when broader market conditions create uncertainty.
Top 10 Dividend Stocks In Australia
| Name | Dividend Yield | Dividend Rating |
| Bisalloy Steel Group (ASX:BIS) | 9.56% | ★★★★★☆ |
| IPH (ASX:IPH) | 7.80% | ★★★★★☆ |
| Sugar Terminals (NSX:SUG) | 8.20% | ★★★★★☆ |
| Accent Group (ASX:AX1) | 7.18% | ★★★★★☆ |
| Super Retail Group (ASX:SUL) | 9.22% | ★★★★★☆ |
| Lindsay Australia (ASX:LAU) | 7.26% | ★★★★★☆ |
| MFF Capital Investments (ASX:MFF) | 3.90% | ★★★★★☆ |
| Nick Scali (ASX:NCK) | 3.54% | ★★★★★☆ |
| Lycopodium (ASX:LYL) | 7.16% | ★★★★★☆ |
| Fiducian Group (ASX:FID) | 4.74% | ★★★★★☆ |
Click here to see the full list of 30 stocks from our Top ASX Dividend Stocks screener.
Here's a peek at a few of the choices from the screener.
Bisalloy Steel Group
Simply Wall St Dividend Rating: ★★★★★☆
Overview: Bisalloy Steel Group Limited manufactures and sells quenched and tempered, high-tensile, and abrasion-resistant steel plates in Australia, Indonesia, Thailand, and internationally with a market cap of A$161.33 million.
Operations: I’m sorry, but there are no specific revenue segment figures provided in the text for Bisalloy Steel Group Limited.
Dividend Yield: 9.6%
Bisalloy Steel Group offers a high dividend yield of 9.56%, ranking in the top 25% among Australian dividend payers, although its dividend history has been volatile over the past decade. The company maintains sustainable payout ratios, with dividends covered by earnings (81.2%) and cash flows (66.6%). Recent inclusion in the S&P/ASX All Ordinaries Index may enhance visibility, despite recent sales decline to A$70.94 million from A$76.65 million year-over-year.
Medibank Private
Simply Wall St Dividend Rating: ★★★★☆☆
Overview: Medibank Private Limited offers private health insurance and health services in Australia, with a market cap of A$12.48 billion.
Operations: Medibank Private Limited's revenue is primarily derived from its Health Insurance segment, which generated A$8.06 billion, and its Medibank Health segment, contributing A$447.10 million.
Dividend Yield: 3.7%
Medibank Private's dividend yield of 3.66% is below the top quartile in Australia, with dividends not well covered by earnings due to a high payout ratio of 96.7%. Despite stable and reliable dividend growth over the past decade, recent legal challenges related to a cybercrime event may affect future payouts. The company reported slight declines in net income and EPS for the half-year ending December 2024, yet announced an ordinary dividend increase to A$0.078 per share.